A reduction in tau protein lessens seizure severity in various epilepsy models, ranging from pharmacologically induced seizure (DeVos et al., 2013; Li et al., 2014) to genetic models (Holth et al., 2013; Gheyara et al., 2014). Here, MAPT is linked to epilepsy.